Trials / Conditions / ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
3 registered clinical trials studyying ATTR-CM (Transthyretin Amyloid Cardiomyopathy) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Ge NCT07494656 | Pfizer | — |
| Recruiting | US Benchmarking Clinical Study NCT07215715 | eMyosound SAS | — |
| Active Not Recruiting | Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopath NCT04801329 | Pfizer | — |